FDA Fills Advisory Panel Seats As Hill Mulls Laxer Conflict Rules

Washington Drug Letter
As Congress continues to push for more relaxed conflict-of-interest rules for FDA advisory committee members, the agency has reduced the panels’ vacancy rate from 35 percent to 20 percent in the last year.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00